Medline Inc.

Medline Inc.

MDLN
Medline Inc.US flagNASDAQ Global Select
36.59
USD
+0.29
- -
30.94BMarket Cap
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
- -
- -
35.01
21.16
Basic EPS, GAAP
- -
- -
- -
1.43
0.34
Free Cash Flow per Basic Share
- -
-0.15
- -
1.6
0.94
Dividend per Share
- -
- -
- -
0.64
0.09
Book Value per Share
- -
- -
- -
13.22
13.19
Tangible Book Value per Share
- -
- -
- -
-13.84
-11.45
Basic Weighted Avg Shares
1,828
1,828
1,828
812
1,078
Sales/Revenue/Turnover
- -
- -
- -
28,432
22,824
Operating Margin (%)
- -
- -
- -
7.78
5.44
Depreciation Expense
- -
- -
- -
1,011
771
Net Income, GAAP
- -
- -
- -
1,159
371
Effective Tax Rate (%)
- -
- -
- -
7.29
23.77
Profit Margin (%)
- -
- -
- -
4.08
1.63
Working Capital
- -
- -
- -
8,189
9,032
LT Debt
- -
- -
- -
12,484
12,548
Total Equity
- -
- -
- -
19,286
19,077
Return on Invested Capital (%)
- -
- -
- -
12.87
5.98
Return on Capital (%)
- -
- -
- -
11.99
3.55
Return on Common Equity (%)
- -
- -
- -
21.59
6.41

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
143
142
92
LT Borrowings
12,484
12,495
12,548
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
812
846
877
Market Capitalization
34,104
37,647
34,589

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
10,679
11,180
11,742
Cash, Cash Equivalents & STI
1,939
2,236
2,677
Accounts Receivable, Net
3,533
3,674
3,661
Inventories
4,769
4,807
4,665
Total Current Liabilities
2,490
2,536
2,710
Payables & Accruals
1,945
1,994
2,104
ST Debt
143
142
92
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
-571.64%
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
6,644
- -
- -
7,787
28,432
2026
7,352
7,685
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
0.18
- -
- -
0.22
1.43
2026
0.16
0.07
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
0.12
0.64
2026
- -
- -
- -
- -
- -

Company Description

CEO
James Boyle
Full Time Employees
45,000
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
3 Lakes Drive Northfield IL United States of America 60093
IPO Date
Dec 17, 2025
Business
Medline Industries, Inc. operates as a leading healthcare supply company that manufactures, distributes, and distributes and sources medical and surgical products to healthcare institutions, home health, hospice, physician offices, and related care settings worldwide. Founded in 1966 and headquartered in Northfield, Illinois, Medline expands its footprint through a broad product portfolio and global distribution network to serve hospitals, clinics, long-term care facilities, and homecare providers across North America, Europe, the Middle East, Africa, and Latin America. Main products and services - Core product categories: medical and surgical supplies; skin care, wound care, and incontinence products; infection prevention solutions; nursing and patient care disposables; gloves, textiles, and apparel; nutrition and enteral feeding supplies; respiratory and anesthesia products; central sterile and sterilization solutions; beds, mattresses, and patient furniture; medical furniture and equipment; clinical textiles and laundry services. - Surgical solutions and instruments: surgical instruments and related disposables; sterile drapes and packs; sterile processing supplies; operating room integration products; single-use devices and consumables for procedures. - Healthcare equipment and technology: patient monitoring basics, mobility aids, hospital beds and mattresses, clinical electronics and basic instrumentation; equipment rentals and service offerings in some markets. - Private label and custom solutions: private-label product lines; supply chain optimization services; category management and procurement outsourcing; healthcare facility consulting and workflow optimization. - Distribution and services: nationwide and international distribution across multiple fulfillment centers; inventory management; order processing; just-in-time delivery; training and assistance with product implementation and infection control programs. Latest major company changes - Strategic expansion of product offerings through acquisitions (notably broadening sterile drape and surgical solutions portfolio) and ongoing international expansion to increase global market reach. - Strengthening end-to-end supply chain capabilities with enhanced private-label options and supplier consolidation to improve cost efficiency and service levels. - Introduction of expanded sterile processing and temperature-management product lines as part of a broader operating room solutions strategy. - Ongoing investments in international markets, including expansion of regional branches and distribution networks to support growth outside North America. - Leadership and organizational realignments to support rapid growth and integration of acquired product lines and new markets. Additional context - Industry and segments: healthcare supplies and equipment; hospital and clinical supply distribution; infection prevention and wound care; medical-surgical products; centralized sterile and operating room solutions. - Target markets: hospitals and health systems, ambulatory surgery centers, long-term care facilities, home health agencies, physician offices, and managed care organizations. - Geographic operations: strong presence in North America with growing international footprint in Europe, Middle East, Africa, and Latin America; regional offices and distribution centers support global logistics. - Corporate structure: private company with a broad network of distribution centers; operates with a centralized sourcing and distribution model to support large healthcare customers. - Subsidiaries/affiliates: operates a network of regional subsidiaries and distribution affiliates to service various geographic markets and customer segments.

Company News

  • Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference

  • Kaplan Fox Notifies Medline Inc. (MDLN) Investors of a Securities Investigation into the Company

  • Kaplan Fox & Kilsheimer LLP Announces an Investigation into Medline Inc. (MDLN) for Possible Securities Law Violations

  • Kaplan Fox Encourages Investors of Medline Inc. (MDLN) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation

  • Kaplan Fox Alerts Medline Inc. (MDLN) Investors to an Investigation of Potential Securities Law Violations

  • Kaplan Fox Announces a Securities Investigation into Medline Inc. (MDLN) - Investors Encouraged to Contact the Firm

  • Kaplan Fox Encourages Investors of Medline Inc. (MDLN) to Contact the Firm to Learn About Their Legal Rights

  • MDLN INVESTIGATION: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

  • Kaplan Fox is Investigating Medline Inc. (MDLN) for Potential Violations of the Federal Securities Laws

  • MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

  • Kaplan Fox & Kilsheimer LLP is Investigating Medline Inc. (MDLN) for Possible Securities Law Violations

  • Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

  • Kaplan Fox Reminds Medline Inc. (MDLN) Investors of an Investigation into Potential Securities Law Violations

  • MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

  • MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

  • Kaplan Fox is Investigating Medline Inc. (MDLN) on Behalf of Investors for Potential Securities Law Violations

  • Kaplan Fox is Investigating Medline Inc. (MDLN) and Encourages Investors Who Suffered Losses to Contact the Firm

  • Medline $MDLN Shares Acquired by Cetera Investment Advisers

  • NASDAQ: MDLN Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm

  • Kaplan Fox Encourages Investors of Medline Inc. (MDLN) Who Suffered Losses to Contact the Firm Regarding a Securities Investigation